Evidence map›Paper›PMID 37042993›Full record

ArticleAnalytical and bioanalytical chemistry2023

ECL sensor for selective determination of citrate ions as a prostate cancer biomarker using polymer of intrinsic microporosity-1 nanoparticles/nitrogen-doped carbon quantum dots.

Hosein Afshary, Mandana Amiri, Frank Marken, Neil B McKeown, Mahdi Amiri

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Quantum Dot-Enabled Biosensing for Prostate Cancer Diagnostics.Nanomaterials (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Hosein AfsharyDepartment of Chemistry, University of Mohaghegh Ardabili, Ardabil, 59166-11367, Iran.
Mandana AmiriDepartment of Chemistry, University of Mohaghegh Ardabili, Ardabil, 59166-11367, Iran. mandanaamiri@uma.ac.ir.
Frank MarkenDepartment of Chemistry, University of Bath, Bath, BA2 7AY, UK.
Neil B McKeownSchool of Chemistry, University of Edinburgh, David Brewster Road, Edinburgh, EH9 3FJ, UK.
Mahdi AmiriImam Hossein Hospital, Social Security Organization, Zanjan Branch, Zanjan, Iran.
University of Mohaghegh Ardabili · IRImam Hossein Hospital · IRUniversity of Bath · GBUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urine citrate analysis is relevant in the screening and monitoring of patients with prostate cancer and calcium nephrolithiasis. A sensitive, fast, easy, and low-maintenance electrochemiluminescence (ECL) method with conductivity detection for the analysis of citrate in urine is developed and validated by employing polymer of intrinsic microporosity-1 nanoparticles/nitrogen-doped carbon quantum dots (nano-PIM-1/N-CQDs). Using optimum conditions, the sensor was applied in ECL experiments in the presence of different concentrations of citrate ions. The ECL signals were quenched gradually by the increasing citrate concentration. The linear range of the relationship between the logarithm of the citrate concentration and ΔECL (ECL of blank - ECL of sample) was obtained between 1.0 × 10

Indexed as

NanoparticlesProstatic NeoplasmsQuantum DotsBiomarkers, TumorCarbonCitric AcidElectrochemical TechniquesHumansLuminescent MeasurementsMaleNitrogenProstateBiomarkers, TumorCarbonCitric AcidNitrogenCarbon dotsCitrateElectrochemiluminescencePIM-1Prostate cancer biomarker

Identifiers

PMID37042993
OpenAlexW4365136364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.